Prothymosin alpha pseudogene 11 (PTMAP11)

Prothymosin alpha pseudogene 11 (PTMAP11) is a processed pseudogene in the human genome, classified under the prothymosin alpha gene family. Unlike its functional paralog PTMA (which encodes prothymosin alpha, a polypeptide involved in immune response and cell proliferation), PTMAP11 does not code for a functional protein due to the lack of necessary gene elements and no evidence of expression[4][5][7][9]. The known prothymosin alpha pseudogenes, including PTMAP11, are not directly associated with disease or targeted by therapeutics, and there are no known interacting drugs or biomarker roles. PTMAP11 is referenced in genomic and gene nomenclature databases, such as HGNC (HGNC:53979), but does not have a defined biological or clinical function[1][3][5][7][9]. Key notes: - PTMAP11 is a pseudogene, not a functional receptor, enzyme, transporter, or signaling entity; it is not considered a drug target[4][5][7]. - No aliases or alternative names beyond its systematic nomenclature. - The only functional, protein-coding gene in this family is PTMA; the pseudogenes (including PTMAP11) demonstrate no protein-coding activity and have not been implicated in disease or therapy[4][5][7]. - There is no evidence in major databases or literature for clinical, pharmacological, or biomarker associations. Entries such as "PTMAP11" are sometimes misinterpreted as targets, but in this case it should not be treated as a valid therapeutic, biological, or diagnostic target[4][5][7].